Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy Volunteers

A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes

NCT06698575 ·Status: COMPLETED ·Phase: PHASE1

The Bioequivalence Study of Acyclovir 800 mg Tablet in Healthy Thai Volunteers Under Fasting Conditions

NCT06228430 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

NCT01390805 ·Status: COMPLETED

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir

NCT01689285 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

NCT00079911 ·Status: TERMINATED ·Phase: PHASE4

Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons

NCT01026454 ·Status: COMPLETED ·Phase: PHASE4

Bioequivalence of Two Formulations of Acyclovir

NCT02255734 ·Status: COMPLETED ·Phase: PHASE4

A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients

NCT00002000 ·Status: COMPLETED ·Phase: NA

Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding

NCT01448616 ·Status: COMPLETED ·Phase: PHASE4

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

NCT02265913 ·Status: COMPLETED ·Phase: PHASE3

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

NCT00042328 ·Status: COMPLETED ·Phase: PHASE2

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

NCT00465205 ·Status: COMPLETED ·Phase: PHASE3

A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients

NCT00001038 ·Status: COMPLETED ·Phase: PHASE3

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

NCT01059084 ·Status: WITHDRAWN ·Phase: NA

Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions

NCT01321502 ·Status: COMPLETED ·Phase: NA

Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food

NCT02852876 ·Status: COMPLETED ·Phase: PHASE1

A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons

NCT00161434 ·Status: COMPLETED ·Phase: PHASE4

The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients

NCT00002404 ·Status: COMPLETED ·Phase: NA

Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers

NCT06435507 ·Status: COMPLETED ·Phase: PHASE1

Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

NCT01346475 ·Status: COMPLETED ·Phase: PHASE4

Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions

NCT01321515 ·Status: COMPLETED ·Phase: NA

Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?

NCT01176409 ·Status: COMPLETED ·Phase: PHASE3

Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis

NCT00878072 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg

NCT00649974 ·Status: COMPLETED ·Phase: PHASE1

VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2

NCT00306293 ·Status: COMPLETED ·Phase: PHASE4